7-Nitroindazole |
カタログ番号GC12309 |
7-ニトロインダゾールは、抗侵害受容作用と心血管作用を持つ選択的 nNOS 阻害剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2942-42-9
Sample solution is provided at 25 µL, 10mM.
評判の良い論文で引用されたGlpBio製品
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 2942-42-9 | SDF | |
Chemical Name | 7-nitro-1H-indazole | ||
Canonical SMILES | [O-][N+](C1=C2NN=CC2=CC=C1)=O | ||
Formula | C7H5N3O2 | M.Wt | 163.14 |
溶解度 | ≥ 5.85mg/mL in DMSO | Storage | Desiccate at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.1297 mL | 30.6485 mL | 61.297 mL |
5 mM | 1.2259 mL | 6.1297 mL | 12.2594 mL |
10 mM | 0.613 mL | 3.0649 mL | 6.1297 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC41605 2-Pyrimidine Acetic Acid
- GC16127 Topiroxostat
- GC16212 Empagliflozin (BI 10773)
- GC42011 1-Oleoyl Lysophosphatidic Acid
- GC50435 PSB CB5
- GC14000 6-fluoro-DL-Tryptophan
- GC40507 (1R,3S)-3-Hydroxycyclopentane carboxylic acid methyl ester
- GC11469 TASIN-1
- GC39744 CR-1-31-B
- GC13450 PD 145305
- GC33976 4',7-Dimethoxyisoflavone (Dimethoxydaidzein)
- GC61509 GAK inhibitor 49 hydrochloride
- GC34087 Trilaciclib hydrochloride (G1T28 hydrochloride)
- GC40688 C6 D-threo Ceramide (d18:1/6:0)
- GC36818 ORY-1001(trans)
- GC60326 Rivaroxaban D4
- GC38068 Direct Black 38
レビュー
Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *